Age-Specific Frequencies of Antibodies to Escherichia coli Verocytotoxins (Shiga Toxins) 1 and 2 among Urban and Rural Populations in Southern Ontario

Journal of Infectious Diseases

Volumn 188, Issue 11, 2003, Pages 1724-1729

  Karmali, Mohamed A ^a,c,i   Mascarenhas, Mariola ^a   Petric, Martin ^d,h   Dutil, Lucie ^a   Rahn, Kris ^a   Ludwig, Kerstin ^f   Arbus, Gerald S ^d,e   Michel, Pascal ^a   Sherman, Philip M ^d,e   Wilson, Jeff ^b   Johnson, Roger ^a   Kaper, James B ^g  

^a CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF HAMBURG   (Germany)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

ⁱ HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; UNCLASSIFIED DRUG; VEROCYTOTOXIN 1 ANTIBODY; VEROCYTOTOXIN 2 ANTIBODY; VEROTOXIN 1; VEROTOXIN 2;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; CANADA; ESCHERICHIA COLI; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL POPULATION; SCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOBLOTTING; INFANT; MALE; MIDDLE AGED; RURAL HEALTH; SHIGA-LIKE TOXIN I; SHIGA-LIKE TOXIN II; URBAN HEALTH;

EID: 0348147557     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379726     Document Type: Article

References (25)

1. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18:775-9.
2. Calderwood S, Acheson DWK, Keusch GT, et al. Proposed new nomenclature for SLT (VT) family. American Society for Microbiology News 1996; 62:118-9.
3. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13:60-98.
4. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151:775-82.
5. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2:15-38.
6. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201.
7. Obrig TG, Del Vecchio PJ, Brown JE, et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 1988; 56: 2373-8.
8. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 1989; 160: 994-8.
9. Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185:74-84.
10. Karmali MA. Human immune response and immunity to Shiga toxin (verocytotoxin)-producing Escherichia coli infection. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:236-48.
11. Rowe PC, Orrbine E, Wells GA, McLaine PN. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. J Pediatr 1991; 119:218-24.
12. Griffin PM, Ostroff SM, Tauxe RV, et al. Illnesses associated with Escherichia coli O157:H7 infections: a broad clinical spectrum. Ann Intern Med 1988; 109:705-12.
13. Bielaszewska M, Clarke I, Karmali MA, Petric M. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun 1997; 65:2509-16.
14. Ludwig K, Karmali MA, Smith CR, Petric M. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid. Can J Microbiol 2002; 48:99-103.
15. Richardson SE, Rotman TA, Jay V, et al. Experimental verocytotoxemia in rabbits. Infect Immun 1992; 60:4154-67.
16. Karmali MA, Petric M, Winkler M, et al. Enzyme-linked immunosorbent assay (ELISA) for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol 1994; 32:1457-63.
17. Reymond D, Johnson RP, Karmali MA, et al. Neutralizing antibodies to Escherichia coli Vero cytotoxin O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol 1996; 34: 2053-7.
18. Reymond D, Karmali MA, Clarke I, Winkler M, Petric M. Comparison of the Western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays to measure antibody to verocytotoxin 1. J Clin Microbiol 1997; 35:609-13.
19. Ludwig K, Karmali MA, Sarkim V, et al. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol 2001; 39:2272-9.
20. Petric M, Karmali MA, Richardson S, Cheung R. Purification and biological properties of Escherichia coli verocytotoxin. FEMS Microbiol Letts 1987; 41:63-8.
21. Towbin M, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
22. Karmali MA, Petric M, Bielaszewska M. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J Clin Microbiol. 1999; 37:396-9.
23. Fisher LD, van Belle G, eds: Biostatistics, a methodology for the health sciences. New York: Wiley, 1993.
24. Fleiss JL. "Exact" analysis of a four-fold table. In: Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons, 1981:24-6.
25. Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE. The role of Escherichia coli infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 1993; 110:183-96.